创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Leading Innovator in ELISpot Technology

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-09 14:45
  • Views:

(Summary description)InnoModels Biotechnology has long been recognized for its cutting-edge technologies and outstanding contributions to the life sciences field. In this field, the company is known for its leading ELISpot technology, which provides scientists with important tools and solutions in immunology research, biomedical research and vaccine development

InnoModels Biotechnology: Leading Innovator in ELISpot Technology

(Summary description)InnoModels Biotechnology has long been recognized for its cutting-edge technologies and outstanding contributions to the life sciences field. In this field, the company is known for its leading ELISpot technology, which provides scientists with important tools and solutions in immunology research, biomedical research and vaccine development

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-09 14:45
  • Views:
Information

InnoModels Biotechnology has long been recognized for its cutting-edge technologies and outstanding contributions to the life sciences field. In this field, the company is known for its leading ELISpot technology, which provides scientists with important tools and solutions in immunology research, biomedical research and vaccine development.
Superb applications of ELISpot technology
InnoModels Bio's ELISpot technology is a highly sensitive method for the detection of substances secreted by individual cells. The technology is not only capable of quantitatively analyzing proteins produced by cells, but also of studying the function and activity of immune cells. This has a wide range of applications in areas such as immune monitoring, vaccine development and cancer immunotherapy.
High sensitivity and versatility
InnoModels's ELISpot technology is favored for its excellent sensitivity and versatility. Researchers can use this technology to accurately detect and analyze proteins produced by cells, whether they are cytokines, antibodies or other molecules. This highly sensitive detection makes ELISpot technology play a key role in discovering new biomarkers, evaluating vaccine efficacy, and more.

 


Broad applicability to a wide range of research areas
InnoModels Bio's ELISpot technology covers a wide range of research areas, including immunology, infectious agent research, autoimmune diseases, tumor immunology, and more. Its flexibility and customizability enable researchers to tailor it to specific research needs and meet experimental requirements in different fields.
Customer Training and Technical Support
As a company focused on customer satisfaction, InnoModels Biotechnology not only provides advanced ELISpot technology, but is also committed to providing comprehensive training and technical support to users. Through online training, seminars and a professional technical support team, the company ensures that users are able to fully understand and properly apply ELISpot technology to maximize its benefits.
Continuous Innovative Development
InnoModels Biotechnology continues to invest in research and development in the field of ELISpot technology, launching new products and technological innovations. Close collaboration with academic and industrial partners keeps the company at the forefront of technology and meets the constant demand for efficient and reliable immunoassay tools in the research field.
Summary
With its innovative and superior application of ELISpot technology, InnoModels Biotechnology has provided scientists around the world with unprecedented research tools. Its high sensitivity, versatility and broad applicability make ELISpot technology irreplaceable in all areas of life science research. Please feel free to contact us if you have any questions or need more information.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司